AAIPharma appoints Maffuid as EVP

Wednesday, April 27, 2011 11:57 AM

AAIPharma Services, a provider of pharmaceutical product development and manufacturing services, has appointed Dr. Paul Maffuid as executive vice president of operations.

Maffuid has 27 years of experience in pharmaceutical and biopharmaceutical product development, where he has been an entrepreneur and served in leadership roles. Most recently, he served as president of Biopharmalogics, a provider of drug product consulting services.  Maffuid was also employed in leadership roles at Arena Pharmaceuticals, Amylin Pharmaceuticals, Magellan Laboratories, Cabrillo Laboratories and Glaxo Research Institute.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs